AIM VACCINE (06660) Income Statement & Earnings

1.960
-0.290-12.89%

15min DelayMarket Closed Jun 12 16:07 CST

2.40BMarket Cap-3.21P/E (TTM)

AIM VACCINE (06660) Income Statement

All

YOY

Hide blank lines

(FY)Dec 31, 2025

(Q6)Jun 30, 2025

(FY)Dec 31, 2024

(Q6)Jun 30, 2024

(FY)Dec 31, 2023

(Q6)Jun 30, 2023

(FY)Dec 31, 2022

(FY)Dec 31, 2021

(Q6)Jun 30, 2021

(FY)Dec 31, 2020

Turnover

-9.29%1.17B

-4.19%514.66M

8.22%1.29B

-0.61%537.18M

-6.06%1.19B

--540.47M

-19.49%1.26B

-4.14%1.57B

26.53%672.56M

72.12%1.64B

Operating income

-9.29%1.17B

-4.19%514.66M

8.22%1.29B

-0.61%537.18M

-6.06%1.19B

540.47M

-19.49%1.26B

-4.14%1.57B

26.53%672.56M

72.12%1.64B

Cost of sales

-22.30%-405.47M

-16.48%-173.42M

-15.73%-331.52M

-38.09%-148.89M

-21.17%-286.45M

---107.82M

14.17%-236.41M

2.98%-275.43M

-16.74%-124.08M

-29.74%-283.88M

Operating expenses

-22.30%-405.47M

-16.48%-173.42M

-15.73%-331.52M

-38.09%-148.89M

-21.17%-286.45M

-107.82M

14.17%-236.41M

2.98%-275.43M

-16.74%-124.08M

-29.74%-283.88M

Gross profit

-20.27%760.2M

-12.12%341.24M

5.83%953.51M

-10.25%388.29M

-12.32%901.02M

432.65M

-20.63%1.03B

-4.39%1.29B

28.97%548.48M

84.77%1.35B

Selling expenses

2.79%-527.52M

0.08%-232.06M

-9.85%-542.67M

-3.26%-232.24M

-0.17%-494M

---224.9M

-7.18%-493.17M

13.71%-460.11M

-29.33%-228.83M

-61.59%-533.25M

Administrative expenses

9.35%-256.29M

-1.68%-126.25M

-11.18%-282.73M

-7.35%-124.16M

43.59%-254.29M

---115.66M

61.41%-450.76M

-487.82%-1.17B

-1,049.55%-1.03B

-26.41%-198.7M

Research and development expenses

47.33%-191.28M

37.12%-106.96M

42.94%-363.13M

57.32%-170.11M

-27.20%-636.4M

---398.53M

-62.78%-500.31M

-94.82%-307.35M

-202.11%-139.61M

-59.54%-157.76M

Impairment and provision

-1,858.47%-518.76M

-98.19%-7.64M

98.52%-26.49M

-5.10%-3.86M

-6,473.38%-1.79B

---3.67M

-241.00%-27.22M

-866.22%-7.98M

-64.36%-2.5M

-139.28%-826K

-Impairment of intangible assets

---211.08M

----

---1.51B

----

-Impairment of property, machinery and equipment

-861.02%-314.69M

----

46.40%-32.75M

----

---61.09M

----

-Goodwill impairment

----

---211.44M

----

-Other impairment is provision

12.02%7.01M

-98.19%-7.64M

249.71%6.26M

-5.10%-3.86M

84.64%-4.18M

---3.67M

-241.00%-27.22M

-866.22%-7.98M

-64.36%-2.5M

-139.28%-826K

Special items of operating profit

-21.07%24.93M

-33.58%8.48M

-31.05%31.58M

-34.15%12.77M

29.69%45.8M

--19.39M

-33.02%35.32M

38.49%52.73M

126.16%25.09M

103.92%38.07M

Operating profit

-208.24%-708.71M

4.73%-123.19M

89.67%-229.92M

55.52%-129.31M

-445.16%-2.23B

-290.72M

31.46%-408.47M

-218.81%-596M

-772.10%-823.11M

199.40%501.63M

Financing cost

4.86%-57.84M

5.11%-28.47M

-38.70%-60.8M

-56.60%-30M

-70.60%-43.83M

---19.16M

-140.05%-25.69M

32.01%-10.7M

46.05%-5.41M

-46.01%-15.74M

Earning before tax

-163.68%-766.56M

4.80%-151.66M

87.20%-290.72M

48.59%-159.31M

-422.99%-2.27B

-309.88M

28.44%-434.17M

-224.87%-606.7M

-836.91%-828.53M

209.95%485.89M

Tax

86.36%22.83M

11.51%15.66M

-96.18%12.25M

-73.22%14.05M

57.42%320.4M

--52.45M

394.25%203.54M

19.07%-69.17M

-45.23%-34.77M

-131.34%-85.47M

After-tax profit from continuing operations

-167.08%-743.73M

6.38%-135.99M

85.72%-278.47M

43.57%-145.26M

-745.61%-1.95B

-257.43M

65.88%-230.63M

-268.79%-675.87M

-1,075.54%-863.29M

234.20%400.41M

Earning after tax

-167.08%-743.73M

6.38%-135.99M

85.72%-278.47M

43.57%-145.26M

-745.61%-1.95B

-257.43M

65.88%-230.63M

-268.79%-675.87M

-1,075.54%-863.29M

234.20%400.41M

Minority profit

-5,427.94%-68.27M

18.84%-4.88M

99.81%-1.24M

14.91%-6.01M

-829.72%-649.24M

---7.06M

426.42%88.97M

-20.00%16.9M

-130.54%-1.44M

777.37%21.13M

Profit attributable to shareholders

-143.64%-675.46M

5.84%-131.12M

78.69%-277.23M

44.38%-139.25M

-307.07%-1.3B

-250.37M

53.87%-319.6M

-282.65%-692.77M

-1,128.88%-861.85M

223.06%379.29M

Basic earnings per share

-139.13%-0.55

0.00%-0.11

78.50%-0.23

47.62%-0.11

-296.30%-1.07

-0.21

55.00%-0.27

-253.85%-0.6

-955.56%-0.77

178.57%0.39

Diluted earnings per share

-139.13%-0.55

0.00%-0.11

78.50%-0.23

47.62%-0.11

-296.30%-1.07

-0.21

55.00%-0.27

-253.85%-0.6

-955.56%-0.77

178.57%0.39

Currency Unit

CNY

Accounting Standards

IAS

Audit Opinions

Unqualified Opinion

Auditor

Ernst & Young

	(FY)Dec 31, 2025	(Q6)Jun 30, 2025	(FY)Dec 31, 2024	(Q6)Jun 30, 2024	(FY)Dec 31, 2023	(Q6)Jun 30, 2023	(FY)Dec 31, 2022	(FY)Dec 31, 2021	(Q6)Jun 30, 2021	(FY)Dec 31, 2020
Turnover	-9.29%1.17B	-4.19%514.66M	8.22%1.29B	-0.61%537.18M	-6.06%1.19B	--540.47M	-19.49%1.26B	-4.14%1.57B	26.53%672.56M	72.12%1.64B
Operating income	-9.29%1.17B	-4.19%514.66M	8.22%1.29B	-0.61%537.18M	-6.06%1.19B	540.47M	-19.49%1.26B	-4.14%1.57B	26.53%672.56M	72.12%1.64B
Cost of sales	-22.30%-405.47M	-16.48%-173.42M	-15.73%-331.52M	-38.09%-148.89M	-21.17%-286.45M	---107.82M	14.17%-236.41M	2.98%-275.43M	-16.74%-124.08M	-29.74%-283.88M
Operating expenses	-22.30%-405.47M	-16.48%-173.42M	-15.73%-331.52M	-38.09%-148.89M	-21.17%-286.45M	-107.82M	14.17%-236.41M	2.98%-275.43M	-16.74%-124.08M	-29.74%-283.88M
Gross profit	-20.27%760.2M	-12.12%341.24M	5.83%953.51M	-10.25%388.29M	-12.32%901.02M	432.65M	-20.63%1.03B	-4.39%1.29B	28.97%548.48M	84.77%1.35B
Selling expenses	2.79%-527.52M	0.08%-232.06M	-9.85%-542.67M	-3.26%-232.24M	-0.17%-494M	---224.9M	-7.18%-493.17M	13.71%-460.11M	-29.33%-228.83M	-61.59%-533.25M
Administrative expenses	9.35%-256.29M	-1.68%-126.25M	-11.18%-282.73M	-7.35%-124.16M	43.59%-254.29M	---115.66M	61.41%-450.76M	-487.82%-1.17B	-1,049.55%-1.03B	-26.41%-198.7M
Research and development expenses	47.33%-191.28M	37.12%-106.96M	42.94%-363.13M	57.32%-170.11M	-27.20%-636.4M	---398.53M	-62.78%-500.31M	-94.82%-307.35M	-202.11%-139.61M	-59.54%-157.76M
Impairment and provision	-1,858.47%-518.76M	-98.19%-7.64M	98.52%-26.49M	-5.10%-3.86M	-6,473.38%-1.79B	---3.67M	-241.00%-27.22M	-866.22%-7.98M	-64.36%-2.5M	-139.28%-826K
-Impairment of intangible assets	---211.08M	----	----	----	---1.51B	----	----	----	----	----
-Impairment of property, machinery and equipment	-861.02%-314.69M	----	46.40%-32.75M	----	---61.09M	----	----	----	----	----
-Goodwill impairment	----	----	----	----	---211.44M	----	----	----	----	----
-Other impairment is provision	12.02%7.01M	-98.19%-7.64M	249.71%6.26M	-5.10%-3.86M	84.64%-4.18M	---3.67M	-241.00%-27.22M	-866.22%-7.98M	-64.36%-2.5M	-139.28%-826K
Special items of operating profit	-21.07%24.93M	-33.58%8.48M	-31.05%31.58M	-34.15%12.77M	29.69%45.8M	--19.39M	-33.02%35.32M	38.49%52.73M	126.16%25.09M	103.92%38.07M
Operating profit	-208.24%-708.71M	4.73%-123.19M	89.67%-229.92M	55.52%-129.31M	-445.16%-2.23B	-290.72M	31.46%-408.47M	-218.81%-596M	-772.10%-823.11M	199.40%501.63M
Financing cost	4.86%-57.84M	5.11%-28.47M	-38.70%-60.8M	-56.60%-30M	-70.60%-43.83M	---19.16M	-140.05%-25.69M	32.01%-10.7M	46.05%-5.41M	-46.01%-15.74M
Earning before tax	-163.68%-766.56M	4.80%-151.66M	87.20%-290.72M	48.59%-159.31M	-422.99%-2.27B	-309.88M	28.44%-434.17M	-224.87%-606.7M	-836.91%-828.53M	209.95%485.89M
Tax	86.36%22.83M	11.51%15.66M	-96.18%12.25M	-73.22%14.05M	57.42%320.4M	--52.45M	394.25%203.54M	19.07%-69.17M	-45.23%-34.77M	-131.34%-85.47M
After-tax profit from continuing operations	-167.08%-743.73M	6.38%-135.99M	85.72%-278.47M	43.57%-145.26M	-745.61%-1.95B	-257.43M	65.88%-230.63M	-268.79%-675.87M	-1,075.54%-863.29M	234.20%400.41M
Earning after tax	-167.08%-743.73M	6.38%-135.99M	85.72%-278.47M	43.57%-145.26M	-745.61%-1.95B	-257.43M	65.88%-230.63M	-268.79%-675.87M	-1,075.54%-863.29M	234.20%400.41M
Minority profit	-5,427.94%-68.27M	18.84%-4.88M	99.81%-1.24M	14.91%-6.01M	-829.72%-649.24M	---7.06M	426.42%88.97M	-20.00%16.9M	-130.54%-1.44M	777.37%21.13M
Profit attributable to shareholders	-143.64%-675.46M	5.84%-131.12M	78.69%-277.23M	44.38%-139.25M	-307.07%-1.3B	-250.37M	53.87%-319.6M	-282.65%-692.77M	-1,128.88%-861.85M	223.06%379.29M
Basic earnings per share	-139.13%-0.55	0.00%-0.11	78.50%-0.23	47.62%-0.11	-296.30%-1.07	-0.21	55.00%-0.27	-253.85%-0.6	-955.56%-0.77	178.57%0.39
Diluted earnings per share	-139.13%-0.55	0.00%-0.11	78.50%-0.23	47.62%-0.11	-296.30%-1.07	-0.21	55.00%-0.27	-253.85%-0.6	-955.56%-0.77	178.57%0.39
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS
Audit Opinions	--	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	Unqualified Opinion	--	Unqualified Opinion
Auditor	--	--	Ernst & Young	--	Ernst & Young	--	Ernst & Young	Ernst & Young	--	Ernst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More

牛牛課堂

Oct 13, 2025 18:05

[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?

Food流油

Apr 14, 2025 15:43

"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"